{
    "clinical_study": {
        "@rank": "60519", 
        "arm_group": [
            {
                "arm_group_label": "ReCell\u00ae", 
                "arm_group_type": "Experimental", 
                "description": "ReCell\u00ae with skin graft"
            }, 
            {
                "arm_group_label": "skin graft", 
                "arm_group_type": "Active Comparator", 
                "description": "split-thickness skin graft as control group"
            }
        ], 
        "brief_summary": {
            "textblock": "Diabetic foot ulcer is one of the refractory wounds and always poses many challenges in\n      clinical practice. This study was conducted to have a prospective, randomised, controlled\n      study compare the safety and efficacy of the ReCell\u00ae technology with skin graft (experiment\n      group) with split-thickness skin graft (STSG, control group) alone on treating diabetic foot\n      ulcers."
        }, 
        "brief_title": "Study of ReCell\u00ae Treating for Diabetic Foot Ulcers", 
        "completion_date": {
            "#text": "June 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Diabetic Foot Ulcer", 
        "condition_browse": {
            "mesh_term": [
                "Ulcer", 
                "Foot Ulcer", 
                "Diabetic Foot"
            ]
        }, 
        "detailed_description": {
            "textblock": "The primary objective of this study is to assess the effectiveness and safety of ReCell\u00ae\n      with skin graft (experiment group) vs. skin graft (control group) for the treatment of\n      non-healing diabetic foot ulcers. Our hypothesis is that the methods of experiment group is\n      better than the control group."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Patients aged over 18 years old\n\n          -  with a diagnosis of type 1 or type 2 diabetes\n\n          -  who had a diabetic low extremity ulcer last for over 4 weeks\n\n          -  with a stage 2 by Wagner's scale\n\n          -  size more than 3 cm2\n\n          -  absence of vascular reconstruction (ankle brachial indices between 0.7 and 1.2)\n\n          -  had indications of skin grafting were eligible for inclusion\n\n        Exclusion Criteria:\n\n          -  patients with medical conditions that would impair wound healing (e.g. malignancy,\n             autoimmune disease),\n\n          -  using corticosteroids or immunosuppressor\n\n          -  a high anesthesiology or surgical risk\n\n          -  uncontrolled hyperglycemia (preoperative HbA1c greater than 12.0%)"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "85 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "80", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "February 22, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02070835", 
            "org_study_id": "SYSU-2013-048"
        }, 
        "intervention": [
            {
                "arm_group_label": "ReCell\u00ae", 
                "description": "ReCell\u00ae and skin graft", 
                "intervention_name": "ReCell\u00ae", 
                "intervention_type": "Device"
            }, 
            {
                "arm_group_label": "skin graft", 
                "description": "split-thickness skin graft", 
                "intervention_name": "skin graft", 
                "intervention_type": "Procedure"
            }
        ], 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "keyword": [
            "Diabetic Foot Ulcer", 
            "ReCell"
        ], 
        "lastchanged_date": "February 25, 2014", 
        "location": {
            "contact": {
                "email": "willway128@163.com", 
                "last_name": "Zhicheng Hu, doctor", 
                "phone": "+86 02087755766", 
                "phone_ext": "8235"
            }, 
            "facility": {
                "address": {
                    "city": "Guangzhou", 
                    "country": "China", 
                    "state": "Guangdong", 
                    "zip": "510080"
                }, 
                "name": "Department of Burn Surgery, The First Affiliated Hospital of Sun Yat-sen University"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "China"
        }, 
        "number_of_arms": "2", 
        "official_title": "ReCell\u00ae Versus Classic Skin Grafts in Treatment of Diabetic Foot Ulcers: a Comparative Randomized Controlled Trial", 
        "other_outcome": {
            "description": "the percentage of subjects that who could not achieved complete wound closure by week 4", 
            "measure": "complication rate", 
            "safety_issue": "Yes", 
            "time_frame": "postsurgery week 4"
        }, 
        "overall_contact": {
            "email": "willway128@163.com", 
            "last_name": "Zhicheng Hu, sub PI", 
            "phone": "+86 02087755766", 
            "phone_ext": "8235"
        }, 
        "overall_official": {
            "affiliation": "Department of Burns, The First Affiliated Hospital, Sun Yat-sen University", 
            "last_name": "Jiayuan Zhu, PI", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "China: Food and Drug Administration", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "June 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "the percentage of subjects that achieved complete wound closure by week 4, herein complete wound closure is defined as skin re-epithelialization without drainage or dressing requirements", 
            "measure": "healing rate", 
            "safety_issue": "No", 
            "time_frame": "postsurgery week 4"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02070835"
        }, 
        "responsible_party": {
            "investigator_affiliation": "First Affiliated Hospital, Sun Yat-Sen University", 
            "investigator_full_name": "Hu Zhicheng", 
            "investigator_title": "FirstSunYetSen", 
            "responsible_party_type": "Sponsor-Investigator"
        }, 
        "secondary_outcome": {
            "description": "the incidence of ulcer recurrence at months 6. Recurrence will be defined as an ulcer occurring at the same location as the healed study ulcer", 
            "measure": "recurrent rate", 
            "safety_issue": "No", 
            "time_frame": "postsurgery months 6"
        }, 
        "source": "First Affiliated Hospital, Sun Yat-Sen University", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Hu Zhicheng", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "March 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "February 2014"
    }
}